Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Metabolic Syndrome and the Risk of Coronary Heart Disease in 367 Patients Treated With Second-Generation Antipsychotic Drugs. PDF $40.00
$40.00
× Placeholder Short-Term Efficacy and Safety of Desvenlafaxine in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women With Major Depressive Disorder PDF $40.00
$40.00
× Placeholder Longer Time to Antipsychotic Treatment Discontinuation for Any Cause Is Associated With Better Functional Outcomes for Patients With Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder PDF $40.00
$40.00
× Placeholder Management of Acute Insomnia and Anxiety in a Patient With Myasthenia Gravis and Respiratory Failure PDF $40.00
$40.00
× Placeholder Prevalence and Correlates of Benzodiazepine Use, Misuse, and Use Disorders Among Adults in the United States PDF $40.00
$40.00
× Placeholder Posttraumatic Stress Disorder Exacerbation as a Result of Public Masking in Times of COVID-19 PDF $40.00
$40.00
× Placeholder Prenatal Psychostimulant and Antidepressant Exposure and Risk of Hypertensive Disorders of Pregnancy PDF $40.00
$40.00
× Placeholder Impact of Invalidation and Trust in Physicians on Health Outcomes in Fibromyalgia Patients PDF $40.00
$40.00
× Placeholder Association Between Pain and Depression Among Older Adults in Europe: Results From the Aged in Home Care (AdHOC) Project: A Cross-Sectional Study PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $360.00
Total $360.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe